Endovascular Today1d
Using Serranator® in Challenging CLTI Cases
Chronic limb-threatening ischemia (CLTI) is a challenging disease to treat, requiring a tailored approach and comprehensive endovascular toolbox. The goal of treatment is to achieve wound healing, ...
Endovascular Today1d
Setting the New Standard for Arterial Thrombectomy
Management of ALI includes anticoagulation, open thrombectomy, surgical bypass, catheter-directed thrombolysis (CDT), endovascular thrombectomy, and a combination of open and endovascular techniques.
Endovascular Today5d
Aneurysm Neck Bridging Devices
Cerenovus PulseRider Aneurysm Neck Bridging Device T shape, Y shape 2.7–3.5, 3.4–4.5 8.6, 10.6 ...
Endovascular Today5d
Dornier MedTech America, Inc.
Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...
Endovascular Today15d
Artivion AMDS Evaluated in PERSEVERE Trial
January 27, 2025—Artivion, Inc. announced the presentation of clinical data from the PERSEVERE United States investigational device exemption (IDE) trial of the company’s AMDS hybrid prosthesis.
Endovascular Today15d
Gore Excluder Conformable AAA Endoprosthesis With Active Control Approved and Launched in Canada
January 27, 2025—Gore & Associates recently announced the first commercial use of the company’s Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis with Active Control system in Canada ...
Endovascular Today15d
Imperative Care’s Zoom System Receives FDA Clearance
January 27, 2025—Imperative Care, Inc. announced that it has received FDA 510(k) clearance of the company’s Zoom system. The comprehensive stroke thrombectomy system includes large-bore 0.088-inch ...
Endovascular Today19d
Aptyx Acquires Medical Murray’s Facility, Forms Aptyx Interventional Systems
January 21, 2025—Aptyx, a Tempe, Arizona–based developer and manufacturer of complex components and devices for the life sciences, announced the acquisition of the Charlotte, North Carolina, facility ...
Endovascular Today19d
Front Line’s COBRA-OS for REBOA Procedures Launched in United Kingdom
January 23, 2025—Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark–approved COBRA-OS—Control of Bleeding, Resuscitation, Arterial Occlusion System—an ...
Endovascular Today21d
Venova Begins VENOS-2 EFS of Velocity pAVF System
January 21, 2025—Venova Medical recently announced the enrollment of the first patients in the company’s VENOS-2 early feasibility study of its Velocity percutaneous arteriovenous fistula (pAVF) ...
Endovascular Today22d
Concept Medical’s SirPAD Trial of MagicTouch PTA Device Completes Enrollment
January 20, 2025—Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percutaneous transluminal angioplasty (PTA) sirolimus-coated ...
Endovascular Today25d
R3 Vascular Secures WCG IRB Approval and CMS Category B Medicare Coverage for ELITE-BTK Pivotal Trial
January 17, 2025—R3 Vascular Inc. recently announced that it received WCG institutional review board (IRB) approval for the ELITE-BTK pivotal trial of its next-generation Magnitude drug-eluting ...